Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of “Hold” by Brokerages

Phibro Animal Health Corporation (NASDAQ:PAHC) has been assigned an average rating of “Hold” from the seven research firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, two have given a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $31.40.

A number of brokerages recently issued reports on PAHC. JPMorgan Chase & Co. raised their price objective on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Finally, Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 9th.

Insider Activity at Phibro Animal Health

In other news, CEO Jack Bendheim sold 38,303 shares of Phibro Animal Health stock in a transaction on Monday, November 10th. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87. Following the completion of the sale, the chief executive officer directly owned 20,577 shares of the company’s stock, valued at approximately $931,932.33. The trade was a 65.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders sold 153,400 shares of company stock worth $6,652,028 in the last ninety days. Company insiders own 50.13% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Phibro Animal Health by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock worth $260,000 after purchasing an additional 546 shares during the period. Millennium Management LLC grew its holdings in shares of Phibro Animal Health by 74.3% in the first quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock valued at $7,733,000 after purchasing an additional 154,281 shares in the last quarter. Jane Street Group LLC increased its stake in Phibro Animal Health by 65.3% during the 1st quarter. Jane Street Group LLC now owns 33,917 shares of the company’s stock worth $724,000 after buying an additional 13,404 shares during the period. State of Alaska Department of Revenue lifted its holdings in Phibro Animal Health by 7.6% during the 2nd quarter. State of Alaska Department of Revenue now owns 12,129 shares of the company’s stock worth $309,000 after buying an additional 859 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in Phibro Animal Health by 10.0% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,530 shares of the company’s stock valued at $294,000 after buying an additional 1,044 shares during the period. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Up 1.2%

Shares of NASDAQ PAHC opened at $39.48 on Tuesday. The company has a market capitalization of $1.60 billion, a P/E ratio of 23.78, a P/E/G ratio of 1.10 and a beta of 0.79. The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35. The company has a 50 day simple moving average of $40.05 and a 200-day simple moving average of $37.63. Phibro Animal Health has a 1 year low of $16.16 and a 1 year high of $46.42.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. The firm had revenue of $363.89 million for the quarter, compared to analysts’ expectations of $345.44 million. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, equities research analysts predict that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio is 28.92%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.